Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean M Winter

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|June 2, 2026
Investigation of a methylated BCAT1 and IKZF1 circulating tumour DNA blood test for monitoring treatment response in patients with colorectal cancerRafha Rafeeu, Erin L Symonds, Michael Z Michael, et al.
Cancer Medicine|March 3, 2025
The Impact of Age on Preferences for Colorectal Cancer Surveillance Strategies: Are Fecal Immunochemical Tests FIT for Surveillance?Maddison Dix, Sarah Cohen-Woods, Molla M Wassie, et al.
Nutrition Research (New York, N.Y.)|September 17, 2016
Dietary butyrylated high-amylose starch reduces azoxymethane-induced colonic O(6)-methylguanine adducts in rats as measured by immunohistochemistry and high-pressure liquid chromatographyRichard K Le Leu, Benjamin L Scherer, Mark T Mano, et al.
Journal of Gastroenterology and Hepatology|March 2, 2024
Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherenceGeraldine Laven-Law, Erin L Symonds, Jean M Winter, et al.
Oncotarget|July 10, 2018
Prostate cancer susceptibility gene <i>HIST1H1A</i> is a modulator of androgen receptor signaling and epithelial to mesenchymal transitionKendra A Williams, Minnkyong Lee, Jean M Winter, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2023
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance ProgramMolla M Wassie, Graeme P Young, Jean M Winter, et al.
Cancer Biomarkers : Section a of Disease Markers|March 7, 2022
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patientsJean M Winter, Lorraine Sheehan-Hennessy, Beibei Yao, et al.
Journal of Gastroenterology and Hepatology|March 9, 2022
Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasiaMolla M Wassie, Graeme P Young, Charles Cock, et al.
Cancer Treatment and Research Communications|August 18, 2024
A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinomaFaridh Raja Mohamed, Anand Rose, Lorraine Sheehan-Hennessy, et al.
Cancer Medicine|March 23, 2026
Lifestyle Changes and Colorectal Neoplasia Risk During Colonoscopy Surveillance: A Stage 1 Registered ReportMolla M Wassie, Jean M Winter, Graeme P Young, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|June 2, 2026
Investigation of a methylated BCAT1 and IKZF1 circulating tumour DNA blood test for monitoring treatment response in patients with colorectal cancerRafha Rafeeu, Erin L Symonds, Michael Z Michael, et al.
Cancer Medicine|March 3, 2025
The Impact of Age on Preferences for Colorectal Cancer Surveillance Strategies: Are Fecal Immunochemical Tests FIT for Surveillance?Maddison Dix, Sarah Cohen-Woods, Molla M Wassie, et al.
Nutrition Research (New York, N.Y.)|September 17, 2016
Dietary butyrylated high-amylose starch reduces azoxymethane-induced colonic O(6)-methylguanine adducts in rats as measured by immunohistochemistry and high-pressure liquid chromatographyRichard K Le Leu, Benjamin L Scherer, Mark T Mano, et al.
Journal of Gastroenterology and Hepatology|March 2, 2024
Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherenceGeraldine Laven-Law, Erin L Symonds, Jean M Winter, et al.
Oncotarget|July 10, 2018
Prostate cancer susceptibility gene <i>HIST1H1A</i> is a modulator of androgen receptor signaling and epithelial to mesenchymal transitionKendra A Williams, Minnkyong Lee, Jean M Winter, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 7, 2023
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance ProgramMolla M Wassie, Graeme P Young, Jean M Winter, et al.
Cancer Biomarkers : Section a of Disease Markers|March 7, 2022
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patientsJean M Winter, Lorraine Sheehan-Hennessy, Beibei Yao, et al.
Journal of Gastroenterology and Hepatology|March 9, 2022
Faecal immunochemical test mitigates risk of delayed colonoscopy in people with elevated risk of colorectal neoplasiaMolla M Wassie, Graeme P Young, Charles Cock, et al.
Cancer Treatment and Research Communications|August 18, 2024
A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinomaFaridh Raja Mohamed, Anand Rose, Lorraine Sheehan-Hennessy, et al.
Cancer Medicine|March 23, 2026
Lifestyle Changes and Colorectal Neoplasia Risk During Colonoscopy Surveillance: A Stage 1 Registered ReportMolla M Wassie, Jean M Winter, Graeme P Young, et al.
Pageof 5